Showing 1 - 7 results of 7 for search 'Joao A de Andrade', query time: 0.03s Refine Results
  1. 1
    Assessment of viral RNA in idiopathic pulmonary fibrosis using RNA-seq

    Assessment of viral RNA in idiopathic pulmonary fibrosis using RNA-seq by Qinyan Yin, Michael J. Strong, Yan Zhuang, Erik K. Flemington, Naftali Kaminski, Joao A. de Andrade, Joseph A. Lasky

    Published 2020-04-01
    Get full text
    Article
  2. 2
    Decrements of body mass index are associated with poor outcomes of idiopathic pulmonary fibrosis patients.

    Decrements of body mass index are associated with poor outcomes of idiopathic pulmonary fibrosis patients. by Tejaswini Kulkarni, Kaiyu Yuan, Thi K Tran-Nguyen, Young-Il Kim, Joao A de Andrade, Tracy Luckhardt, Vincent G Valentine, Daniel J Kass, Steven R Duncan

    Published 2019-01-01
    Get full text
    Article
  3. 3
    Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis

    Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis by Lisa H. Lancaster, Joao A. de Andrade, Joseph D. Zibrak, Maria L. Padilla, Carlo Albera, Steven D. Nathan, Marlies S. Wijsenbeek, John L. Stauffer, Klaus-Uwe Kirchgaessler, Ulrich Costabel

    Published 2017-12-01
    Get full text
    Article
  4. 4
    Association of musculoskeletal involvement with lung function and mortality in patients with idiopathic pulmonary fibrosis

    Association of musculoskeletal involvement with lung function and mortality in patients with idiopathic pulmonary fibrosis by Meenakshi Sridhar, Sandeep Bodduluri, Lanier O’Hare, Scott Blumhoff, Maria del Pilar Acosta Lara, Joao A. de Andrade, Young-Il Kim, Tracy Luckhardt, MerryLynn McDonald, Tejaswini Kulkarni

    Published 2024-02-01
    Get full text
    Article
  5. 5
    Defining the pathway to timely diagnosis and treatment of interstitial lung disease: a US Delphi survey

    Defining the pathway to timely diagnosis and treatment of interstitial lung disease: a US Delphi survey by Scott Beegle, Hyun Joo Kim, Joao A de Andrade, Mary M Salvatore, Anna J Podolanczuk, Amy Hajari Case, David L Hotchkin, Thomas Kaelin, Murali Ramaswamy, Carlos Remolina, Conan Tu

    Published 2023-11-01
    Get full text
    Article
  6. 6
    Expert consensus on the management of adverse events and prescribing practices associated with the treatment of patients taking pirfenidone for idiopathic pulmonary fibrosis: a Delphi consensus study

    Expert consensus on the management of adverse events and prescribing practices associated with the treatment of patients taking pirfenidone for idiopathic pulmonary fibrosis: a Del... by Franck F. Rahaghi, Zeenat Safdar, Anne Whitney Brown, Joao A. de Andrade, Kevin R. Flaherty, Robert J. Kaner, Christopher S. King, Maria L. Padilla, Imre Noth, Mary Beth Scholand, Adrian Shifren, Steven D. Nathan

    Published 2020-07-01
    Get full text
    Article
  7. 7
    Delphi Consensus Recommendations on Management of Dosing, Adverse Events, and Comorbidities in the Treatment of Idiopathic Pulmonary Fibrosis with Nintedanib

    Delphi Consensus Recommendations on Management of Dosing, Adverse Events, and Comorbidities in the Treatment of Idiopathic Pulmonary Fibrosis with Nintedanib by Franck Rahaghi, John A Belperio, John Fitzgerald, Mridu Gulati, Robert Hallowell, Kristin B Highland, Tristan J Huie, Hyun J Kim, Martin Kolb, Joseph A Lasky, Brian D Southern, Jeffrey J Swigris, Joao A de Andrade

    Published 2021-03-01
    Get full text
    Article

Search Tools: